Crystal structures and the solvent-mediated transformation of erythromycin acetone solvate to dihydrate during batch crystallization

Industrial and Engineering Chemistry Research

Volumn 46, Issue 6, 2007, Pages 1851-1858

  Wang, Zhanzhong ^a   Wang, Jingkang ^a   Dang, Leping ^a   Zhang, Meijing ^a  

^a TIANJIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CRYSTAL STRUCTURE; CRYSTALLIZATION; DISSOLUTION; NUCLEATION; SOLVENTS; THERMODYNAMIC STABILITY;

ENANTIOTROPIC SYSTEM; RAPID NUCLEATION; TRANSFORMATION KINETICS;

ACETONE;

ACETONE; CRYSTAL STRUCTURE; CRYSTALLIZATION; DISSOLUTION; NUCLEATION; SOLVENTS; THERMODYNAMIC STABILITY;

EID: 33947504933     PISSN: 08885885     EISSN: None     Source Type: Journal    
DOI: 10.1021/ie061218i     Document Type: Article

References (20)

1. Ferrari, E. S.; Davey, R. J.; Cross, W. I.; Gillon, A. L.; Towler, C. S. Crystallization in polymorphic systems: the solution-mediated transformation of β to α glycine. Cryst. Growth Des. 2003, 3, 53-60.
2. Nangia, A. Pseudopolymorph: retain this widely accepted term. Cryst. Growth Des. 2006, 6, 2-4.
3. Kitamura, M.; Nakamura, K. Effects of solvent composition and temperature on polymorphism and crystallization behavior of thiazole-derivative. J. Cryst. Growth 2002, 236, 676-686.
4. Groen, H.; Roberts, K. J. Nucleation, growth, and pseudo-polymorphic behavior of citric acid as monitored in situ by attenuated total reflection Fourier transform infrared spectroscopy. J. Phys. Chem. B 2001, 105, 10723-10730.
5. Murphy, D.; Rodriguez-Cintron, F.; Langevin, B.; Kelly, R. C.; Rodriguez-Hornedo, N. Solution-mediated phase transformation of anhydrous to dihydrate carbamazepine and the effect of lattice disorder. Int. J. Pharm. 2002, 246, 121-134.
6. Kitamura, M.; Hura, T. Solvent effect on polymorphism in crystallization of BPT propyl ester. Cryst. Growth Des. 2006, 6, 1945-1950.
7. Cindy, G.; Hezekiah, K. C.; Ann, V. S. Investigation of unknown related substances in commercial erythromycin samples with liquid chromatography/mass spectrometry. Mass Spectrom. 2000, 14, 878-884.
8. Giancarlo, L.; Francessco, P.; Gian, G. B. G. Antibiotics - A multidisciplinary approach: Plenum Press: New York, 1995.
9. Fukumori, Y.; Fukuda, T.; Yamamoto, Y.; Shigitani, Y.; Hanyu, Y.; Takeuchi, Y.; Sato, N. Physical characterization of erythromycin dihydrate, anhydrate and amorphous solid and their dissolution properties. Chem. Pharm. Bull. 1983, 31, 4029-4039.
10. Miroshnyk, I.; Khriachtchev, L.; Mirza, S.; Rantanen, J.; Heinamaki, J.; Yliruusi, J. Insight into thermally induced phase transformation of erythromycin A dihydrate. Cryst. Growth Des. 2005, 1-6.
11. Giulietti, M.; Guardani, R.; Nascimento, C. A. O.; Amtz, B. Inline monitoring of crystallization processes using a laser reflection sensor and a neural network model. Chem. Eng. Technol. 2003, 26, 267-272.
12. O'Sullivan, B.; Barrett, P.; Hsiao, G.; Carr, A.; Glennon, B. In situ monitoring of polymorphic transitions. Org. Process Res. Dev. 2003, 7, 977-982.
13. Wang, Z. Z.; Wang, J. K.; Dang, L. P. Nucleation, growth, and solvated behavior of erythromycin as monitored in situ by using FBRM and PVM. Org. Process Res. Dev. 2006, 10, 450-456.
14. O'Sullivan; Glennon, B. Application of in situ FBRM and ATR-FTIR to the monitoring of the polymorphic transformation of D-mannitol. Org. Process Res. Dev. 2005, 9, 884-889.
15. Mullin, J. W. Crystallization, 3rd ed.; Butterwoth-Heinemann: London, 1993; p 257.
16. Donald R. C. U.S. Patent 2864817, December 16, 1958.
17. http://www.ccdc.cam.ac.uk.
18. Maruyama, S.: Ooshima, H.; Kato, J. Crystal structures and solvent-mediated transformation of taltireline polymorphs. Chem. Eng. J. 1999, 75, 193-200.
19. Zhu, H. J.; Xu, J.; Varlashkin, P.; Long, S.; Kidd, C. Dehydration, hydration behavior, and structural analysis of fenoprofen calcium. J. Pharm. Sci. 2001, 90, 845-859.
20. Barrett, P.; Glennon, B. In-line FBRM monitoring of particle size in dilute agitated suspensions. Part. Part. Syst. Charact. 1999, 16, 207-211.